We all can have our preferences on who we would like it to partner or buy us out but at the end of the day I’ll take whoever is willing to put up the highest offer. I will also take whoever wants to support us and at the same time get credit for curing HIV or cancer.

To me, it’s about getting this in the hands of patients and that happening in an expedited timeline; one that also yields a proper share price for the shareholders.